OUR PROCESS

Lobbying and sound policy research is essential to our cause

See how we work

OUR EVENTS

Our events extend beyond the legislative session. Come join us.

Come join the fun

OUR TEAM

Our board member's hard work and dedication make it all happen.

Meet your advocators

Who We are. Our mission

Heart

SMPL is an organization dedicated to statewide coalition building, sound policy research, education and advocacy for substantive drug law reform. We are headquartered in the capitol of Baton Rouge where we lobby at the local and state level, but have affiliates in every major city throughout Louisiana. The SMPL board is a dynamically diverse mix of professionals who share one passion in common for making our laws for marijuana both modernized and civilized. We bring to the task a varied mix of seasoned and younger advocates, different political orientations, ethnicities, sexes, socio-economic backgrounds, birthplaces and skill sets or expertise. By going public with our growing coalition and amplifying publicly available information, we seek to help expose the ulterior motives of the vested drug warriors and undo some of the deep damage that results from the stigmatism of any non-violent fully consenting private consumption of a naturally occurring medicinal plant. learn more

Help Us Reach our Goal

Interested in helping out? SMPL is a 501c4 registered non-profit funded entirely by donations.

Donations
$
75%
Fundraiser
$
60%

Latest News

Charlotte Figi, the little girl who inspired the low-THC medical marijuana strain, “Charlotte’s Web,” has passed away with COVID-19. Multiple family members tested positive for the virus, said those close to the family. As of Tuesday, 179 people have died of coronavirus in Colorado, according to the Colorado Department of Public Health and Environment. Figi had suffered hundreds of grand mal seizures when her parents, exhausted of heavy-duty drugs, sought out the help of the southern Colorado-based Stanley Brothers, who eventually engineered … read more

Epidiolex, the only plant-derived cannabis drug approved by the U.S. Food and Drug Administration, is no longer considered a controlled substance, providing a boost to its manufacturer’s stock price. GW Pharmaceuticals, a biopharmaceutical company based in London, saw its stock go up 5.9% on Tuesday, one day after the U.S. Drug Enforcement Administration said it would no longer classify Epidiolex as a Schedule 5 drug under the federal Controlled Substance Act. Epidiolex is used to treat rare forms of epilepsy. The DEA’s … read more

Adult-use cannabis stores in Illinois sold almost $110 million in products in the first quarter of 2020, state regulators say. In March, stores sold 812,203 marijuana products for a total of $35.9 million, according to the Illinois Department of Financial and Professional Regulations. Recreational retailers in Illinois sold $27.1 million, or 75.5% of total sales, to residents and $8.8 million to out-of-state customers. That total comes on the heels of $34.8 million in adult-use sales in February, the Chicago-Sun Times reported, and $39.2 million in January. … read more

Follow by Email